Back

Microstructural Disruption of the Forceps Minor in Schizophrenia: A Potential Clinical Imaging Biomarker Using Translational DTI

Li, Q.; Pearlson, G. D.; Calhoun, V.

2026-01-29 neuroscience
10.64898/2026.01.28.702301 bioRxiv
Show abstract

Schizophrenia is one of the most complex brain disorders, arising from multidimensional pathophysiological processes that span genetic vulnerability, neurotransmitter dysregulation, structural brain damage, and large-scale brain network dysfunction. Large-scale neuroimaging studies have consistently demonstrated the critical role of frontal brain regions in schizophrenia. Despite substantial progress, the precise localization of structural damage within these regions and the neurobiological mechanisms linking such alterations to disease pathology remain poorly understood. In this study, we included a total of 115 subjects from two sites of the B-SNIP dataset, comprising 60 healthy controls and 55 individuals with schizophrenia. We employed diffusion tensor imaging (DTI) to precisely characterize specific structural alterations in the frontal brain regions associated with schizophrenia. Our findings reveal significant microstructural abnormalities in the forceps minor, a major commissural white-matter tract that serves as a critical interhemispheric bridge between the bilateral frontal lobes. Network-level mapping further demonstrates that the forceps minor is closely integrated with large-scale brain networks, particularly the default mode network, and maintains strong structural connectivity with orbitofrontal regions-both of which are known to exhibit dysfunction in schizophrenia. Moreover, converging evidence suggests that the forceps minor plays an important role in the regulation of social behavior, a core domain of impairment in schizophrenia. Collectively, these findings identify the forceps minor as a promising structural imaging biomarker for schizophrenia and provide novel insights into the microstructural mechanisms underlying the disorder.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Biological Psychiatry
119 papers in training set
Top 0.1%
22.9%
2
Schizophrenia Bulletin
29 papers in training set
Top 0.1%
10.3%
3
Molecular Psychiatry
242 papers in training set
Top 0.6%
4.4%
4
Cell Reports
1338 papers in training set
Top 12%
4.0%
5
Human Brain Mapping
295 papers in training set
Top 2%
3.7%
6
Nature Communications
4913 papers in training set
Top 39%
3.6%
7
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
62 papers in training set
Top 0.4%
3.6%
50% of probability mass above
8
Neuropsychopharmacology
134 papers in training set
Top 0.8%
3.6%
9
Schizophrenia
19 papers in training set
Top 0.2%
3.1%
10
Translational Psychiatry
219 papers in training set
Top 2%
2.8%
11
Science Advances
1098 papers in training set
Top 10%
2.6%
12
Brain
154 papers in training set
Top 2%
2.6%
13
Advanced Science
249 papers in training set
Top 8%
2.1%
14
NeuroImage: Clinical
132 papers in training set
Top 2%
2.1%
15
Neuron
282 papers in training set
Top 5%
2.1%
16
Nature Neuroscience
216 papers in training set
Top 4%
1.9%
17
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 32%
1.7%
18
JAMA Psychiatry
13 papers in training set
Top 0.3%
1.5%
19
Communications Biology
886 papers in training set
Top 11%
1.5%
20
Scientific Reports
3102 papers in training set
Top 63%
1.4%
21
The Journal of Neuroscience
928 papers in training set
Top 7%
1.2%
22
eLife
5422 papers in training set
Top 49%
1.2%
23
Nature Mental Health
18 papers in training set
Top 0.2%
1.1%
24
NeuroImage
813 papers in training set
Top 5%
1.0%
25
Schizophrenia Research
29 papers in training set
Top 0.5%
0.8%
26
Science Bulletin
22 papers in training set
Top 0.7%
0.8%
27
Nature Human Behaviour
85 papers in training set
Top 4%
0.8%
28
PLOS Biology
408 papers in training set
Top 23%
0.7%
29
eneuro
389 papers in training set
Top 11%
0.5%
30
Progress in Neuro-Psychopharmacology and Biological Psychiatry
36 papers in training set
Top 1%
0.5%